Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The most aggressive forms of breast cancer elude cellular control mechanisms in order to expand

25.11.2010
Scientists at IRB Barcelona have provided new data on how certain types of aggressive breast cancer bypass tumour suppression mechanisms.

About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes.

Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth. The study is published this week in the specialized journal Cancer Research.

Certain external molecules bind to the Her family proteins, thus instructing the cell to divide. However, when cells have multiple copies of the Her2 gene, as is the case of HER2+ patients, they show uncontrolled division and do not respect the signals from their milieu. The prospects for HER2+ patients changed dramatically about ten years ago when the drug Herceptin came onto the market. This agent binds to Her2 to inhibit its proliferative activity, thereby leading to an improved prognosis and greater survival.

LIP disobeys the body¡¯s defense system
When cells detect potential harm, they activate a series of protective responses which often lead to cell death or senescence (no growth). All these mechanisms are systems through which the cell can avoid the irreversible errors that lead them to generate tumours. This explains why tumour cells are removed from the body and replaced by healthy ones. In this context, tumour suppression mechanisms are of particular relevance, among these that induced by the hormone TGF-¦Â and the senescence caused by genes that contribute to the development of malignant cells (OIS).

Through experiments using metastatic cells from patients and animal models, the researchers have discovered that Her2 not only accelerates cell division but also evades these cell arrest systems. Her2 stimulates the production of the protein Lip, which deactivates the mechanisms that prevent cell division mediated by TGF-¦Â and the senescence mediated by OIS, thereby leading to accelerated division. ¡°Lip is the baddie in the film. It affects TGF-¦Â and OIS function, both tumour suppression mechanisms¡±, explains Gomis.

Towards more rational drug administration
One of the problems associated with Herceptin is that after long periods of treatment patients begin to develop drug resistance. This study shows that tumour cells that produce an excess of Lip continue to grow in the presence of the drug. This observation indicates that part of the resistance derives from the increase in Lip shown by these individuals.

"In patients that have an alteration in Her2 plus an increase in Lip, treatment with Herceptin may not be as effective. It should be remembered that this drug acts only against the membrane protein Her2", explains Gomis. These discoveries highlight the need to rationalise drug administration, from patient to patient, and to provide new data for the design of novel pharmaceutical agents against cancer that improve its diagnosis and treatment.

This study has involved the collaboration of Joan Massagu¨¦, Chairman of the Cancer Biology and Genetics Program at the Memorial Sloan-Kettering Cancer Center, New York City, assessor to the MetLab at IRB Barcelona, and adjunct director of the same institute, and has been supported by funding from the BBVA Foundation and the Ministry of Science and Innovation.

Reference article:
HER2 Silences Tumor Suppression in Breast Cancer Cells by Switching Expression of C/EBPb Isoforms
Anna Arnal-Estap¨¦, Maria Tarragona, M¨°nica Morales, Marc Guiu, Cristina Nadal, Joan Massagu¨¦ and Roger R. Gomis.

Cancer Research (2010) [DOI: 10.1158/0008-5472.CAN-10-0869]

Nuria Noriega | EurekAlert!
Further information:
http://www.irbbarcelona.org

More articles from Health and Medicine:

nachricht Correct connections are crucial
26.06.2017 | Charité - Universitätsmedizin Berlin

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Touch Displays WAY-AX and WAY-DX by WayCon

27.06.2017 | Power and Electrical Engineering

Drones that drive

27.06.2017 | Information Technology

Ultra-compact phase modulators based on graphene plasmons

27.06.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>